Address
16305 36th Avenue North
Minneapolis, MN 55446
United States of America (the)
Phone
763 392 0767
Website
Sector
Healthcare
Industry
Biotechnology
Employees
155
First IPO Date
September 19, 2017
| Name | Title | Pay | Year Born |
| Brian F. Sullivan | Co-Founder, Chairman & Chief Executive Officer | 945,218 | 1962 |
| Vicky Hahne | Chief Financial Officer | 598,079 | 1966 |
| Lance G. Laing | Co-Founder, Chief Science Officer, Vice President, Secretary & Director | 673,781 | 1962 |
| Igor Gorbatchevsky | Chief Medical Officer | 0 | N/A |
| Jodi Sievers | Head of Investor Relations & Corporate Communications | 0 | N/A |
| Sheri Smith | Acting Head of Clinical Operations | 0 | N/A |
| Eldon C. Mayer | Chief Commercial Officer | 0 | 1961 |
| Brent Eilefson | General Counsel | 0 | N/A |
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.